Back to Industry News
General
EQL Pharma Launches Mellozzan in the UK Awaiting Approval
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Dagens industri
Photo by Precondo CA on Unsplash
Stay updated on stories like this
Key takeaways
- In a sponsored article, Lars Söderfjell, Head of Equities at Ålandsbanken Fonder, emphasizes the importance of a consistent, long-term investment strategy during market volatility
- He advises investors to avoid market timing, highlighting that missing even a few peak trading days can substantially diminish long-term returns
- Söderfjell recommends investors develop a plan aligned with their individual risk tolerance and maintain adherence, resisting the urge to react emotionally to market fluctuations
In a sponsored article, Lars Söderfjell, Head of Equities at Ålandsbanken Fonder, emphasizes the importance of a consistent, long-term investment strategy during market volatility. He advises investors to avoid market timing, highlighting that missing even a few peak trading days can substantially diminish long-term returns.
Söderfjell recommends investors develop a plan aligned with their individual risk tolerance and maintain adherence, resisting the urge to react emotionally to market fluctuations. Ålandsbanken's strategy, he explains, focuses on investing in high-quality companies characterized by strong balance sheets and stable cash flows to minimize risk. This approach has yielded positive results; the bank's dividend portfolio realized a 73.9 percent return from 2020 to 2024, exceeding the benchmark index's 60.9 percent increase.
Beyond investment strategies, the article highlights Ålandsbanken's commitment to environmental sustainability. This includes initiatives such as a GPS tracking program for eider ducks and a project promoting sustainable fishing practices in the Baltic Sea.
Related Topics
EQL PharmaMellozzanMedicemelatoninUK launch
Never miss stories like this